Stock Track | PHARMARON Soars 5.09% Intraday on Capital Increase and Dividend Proposal

Stock Track03-31

PHARMARON's stock surged 5.09% during Tuesday's intraday trading session, following the announcement of several positive corporate actions.

The company's board has proposed to increase its registered capital from RMB 1.778 billion to RMB 1.837 billion, reflecting recent share placements and vesting of restricted shares. This capital increase typically signals growth plans and expansion initiatives that investors view favorably.

Additionally, PHARMARON announced a proposed final cash dividend of RMB2 for every 10 shares for the financial year ended December 2025, returning value to shareholders. The company also completed a management transition with the appointment of an experienced new company secretary, further strengthening its corporate governance structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment